Intra-Cellular Therapies Insider Trades

ITCI

Track insider trading activity from Intra-Cellular Therapies executives and directors. See which insiders are buying and selling ITCI stock.

Trades Last 12 Months

ITCI Price

All Insider Trades for Intra-Cellular Therapies

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.21M 16,757 shares
$131.87
$131.87
Halstead Michael President
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$18.1M 137,389 shares
$131.87
$131.87
Marcus Joel S Director
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.32M 10,000 shares
$132.00
$131.87
Mates Sharon Chairman And CEO
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$116M 876,581 shares
$131.87
$131.87
Narula Sanjeev Executive Vice President & CFO
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.27M 39,978 shares
$131.87
$131.87
Neumann Mark Evp, Chief Commercial Officer
Holding Value $1.73M 13,134 shares
Last Trade
Apr 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 21,876 shares
$131.87
$131.87
Riggs Rory B Director
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.64M 20,000 shares
$131.87
$131.87
Holding Value $0 0 shares
Last Trade
Apr 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$6.55M 49,655 shares
$131.87
$131.87
Durgam Suresh K. Evp, Chief Medical Officer
Holding Value $1.73M 13,134 shares
Last Trade
Apr 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 21,876 shares
$131.87
$131.87
Hineline Lawrence J. SVP Of Finance, CFO
Holding Value $149k 1,129 shares
Last Trade
Mar 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$668k 10,121 shares
$65.96
$131.87
Rawlins Michael Director
Holding Value $2.21M 16,757 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$930k 16,757 shares
$55.48
$131.87
Lerner Richard A Director
Holding Value $12.7M 96,663 shares
Last Trade
Sep 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15k 402 shares
$37.28
$131.87
Holding Value $12.5M 95,000 shares
Last Trade
May 28, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.56M 38,843 shares
$40.12
$131.87
Satlin Andrew EVP And Chief Medical Officer
Holding Value $4.41M 33,417 shares
Last Trade
Feb 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.44M 60,171 shares
$23.94
$131.87
Vanover Kimberly E. Svp, Early Stage Clinical Dev.
Holding Value $10.7M 80,951 shares
Last Trade
Jan 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.78M 139,866 shares
$12.73
$131.87
Davis Robert E Svp, Chief Scientific Officer
Holding Value $9.96M 75,554 shares
Last Trade
Jan 08, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66M 130,542 shares
$12.73
$131.87
Holding Value $521M 3,953,270 shares
Last Trade
Oct 02, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4M 258,065 shares
$15.50
$131.87
Alafi Moshe 10% owner
Holding Value $521M 3,953,270 shares
Last Trade
Oct 02, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4M 258,065 shares
$15.50
$131.87
Fienberg Allen A. VP Of Business Development
Holding Value $0 0 shares
Last Trade
Sep 09, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$318k 12,500 shares
$25.43
$131.87
Wennogle Lawrence P. Vice President, Drug Discovery
Holding Value $16.7M 126,500 shares
Last Trade
Jun 08, 2015 Sale (Open Market)Shares sold on the open market or in a private sale.
$671k 25,000 shares
$26.84
$131.87

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up